Masitinib is a selective oral tyrosine kinase inhibitor that functions by targeting receptor tyrosine kinases to inhibit pathological cell proliferation and migration, primarily used for the treatment… Read more
Masitinib is a selective oral tyrosine kinase inhibitor that functions by targeting receptor tyrosine kinases to inhibit pathological cell proliferation and migration, primarily used for the treatment of mast cell tumors in veterinary medicine. Pharmaceutical laboratories utilize high-quality reference standards of Masitinib and its associated compounds for rigorous analytical testing, method validation, and impurity profiling. The availability of diverse Masitinib impurities, including N-nitroso Masitinib and relevant synthetic intermediates, is essential for identifying degradation products and ensuring compliance with regulatory quality control standards. Furthermore, stable isotope labelled compounds are indispensable internal standards for mass spectrometry-based assays, enabling precise quantification of the drug and its metabolites in complex biological matrices. These reference materials support comprehensive pharmacokinetic studies and help maintain accurate stability monitoring protocols throughout the drug development and manufacturing lifecycle.